Report #2878135

Overview

Sex

Female

Age

Age unknown

State

—

Recovered

Not recovered

Vaccinated

Nov 13, 2025

Onset

—

Days to onset

—

Hospital days

—

Symptoms (3)

Symptom narrative

muscle ache; Patient is cranky which symptoms exacerbate; This is a spontaneous report received from a Physician from medical information team, Program ID. An 86-year-old female patient received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), on 13Nov2025 as dose number unknown, single (Batch/Lot number: unknown), in arm for immunisation; influenza vaccine (FLU [INFLUENZA VACCINE]), on 13Nov2025 as dose number unknown, single, in arm. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: IRRITABILITY (non-serious) with onset 2025, outcome "not recovered", described as "Patient is cranky which symptoms exacerbate"; MYALGIA (non-serious) with onset 2025, outcome "not recovered", described as "muscle ache". Therapeutic measures were taken as a result of myalgia, irritability. Additional information: The physician reported as a caregiver on behalf of her mother who 4 weeks prior was vaccinated with the Prevnar 20 vaccine and had been complaining since about muscle ache; the caller wanted to know what the timeline for the muscle pain was and whether there were any suggestions to alleviate the pain. The reporter stated that her 86-year-old mother, the patient, received the Prevnar 20 vaccine and an unspecified flu vaccine 4 weeks prior in the same arm at the same time, and stated that it was not a pharmacist or an RN who administered it but an assistant. Since receiving the vaccines, the pain had been persistent; ice was used before and after vaccination and warm compresses were currently being used. The patient had also taken Tylenol, Gabapentin daily (sometimes twice daily), topical analgesic pain patches, lidocaine patches, and massages with cream, but nothing helped alleviate the pain; the patient was cranky and symptoms were exacerbated. The physician stated she did not know why she did not call sooner and assumed it would get better, and she was seeking safety information regarding the timeline for muscle pain and possible treatment recommendations to alleviate it. The physician further stated she did not have the lot number and would not make it up, questioned whether four weeks of pain was reasonable, and asked for safety information regarding Prevnar 20. When clarified whether the reporter wanted to proceed with the report, the reporter declined and ended the call; further probing could not be done as the reporter was unwilling to proceed with the report and hung up, and purchase details and other details were unknown, resulting in limited information available from the call. The information on the batch/lot number for pneumococcal 20-val conj vac (dipht CRM197 protein) will be requested and submitted if and when received.